Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 532

1.

Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.

Moriwaki K, Fukuda H.

Osteoporos Int. 2019 Jan 4. doi: 10.1007/s00198-018-4798-9. [Epub ahead of print]

PMID:
30610244
2.

Remote Heart Rate Measurement from RGB-NIR Video Based on Spatial and Spectral Face Patch Selection.

Kado S, Monno Y, Moriwaki K, Yoshizaki K, Tanaka M, Okutomi M.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:5676-5680. doi: 10.1109/EMBC.2018.8513464.

PMID:
30441624
3.

Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.

Ohki K, Kiyokawa N, Saito Y, Hirabayashi S, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fukushima K, Hasegawa D, Fukushima H, Imai M, Kajiwara R, Koike T, Komori I, Matsui A, Mori M, Moriwaki K, Noguchi Y, Park MJ, Ueda T, Yamamoto S, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Takahashi H, Fukushima T, Hayashi Y, Koh K, Manabe A, Ohara A; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2019 Jan;104(1):128-137. doi: 10.3324/haematol.2017.186320. Epub 2018 Aug 31.

4.

Augmented O-GlcNAcylation alleviates inflammation-mediated colon carcinogenesis via suppression of acute inflammation.

Hirata Y, Nakagawa T, Moriwaki K, Koubayashi E, Kakimoto K, Takeuchi T, Inoue T, Higuchi K, Asahi M.

J Clin Biochem Nutr. 2018 May;62(3):221-229. doi: 10.3164/jcbn.17-106. Epub 2018 Mar 17.

5.

TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma.

Moriwaki K, Ayani Y, Kuwabara H, Terada T, Kawata R, Asahi M.

Oncotarget. 2018 May 18;9(38):25225-25243. doi: 10.18632/oncotarget.25396. eCollection 2018 May 18.

6.

Effect of Sitagliptin on Coronary Flow Reserve Assessed by Magnetic Resonance Imaging in Type 2 Diabetic Patients With Coronary Artery Disease.

Moriwaki K, Takeuchi T, Fujimoto N, Sawai T, Sato Y, Kumagai N, Masuda J, Nakamori S, Ishida M, Yamada N, Nakamura M, Sakuma H, Ito M, Dohi K.

Circ J. 2018 Jul 25;82(8):2119-2127. doi: 10.1253/circj.CJ-18-0083. Epub 2018 May 12.

7.

Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation.

Nishino K, Koda S, Kataoka N, Takamatsu S, Nakano M, Ikeda S, Kamamatsu Y, Morishita K, Moriwaki K, Eguchi H, Yamamoto E, Kikkawa F, Tomita Y, Kamada Y, Miyoshi E.

Oncotarget. 2018 Jan 29;9(16):12732-12744. doi: 10.18632/oncotarget.24332. eCollection 2018 Feb 27.

8.

Present developments in reaching an international consensus for a model-based approach to particle beam therapy.

Prayongrat A, Umegaki K, van der Schaaf A, Koong AC, Lin SH, Whitaker T, McNutt T, Matsufuji N, Graves E, Mizuta M, Ogawa K, Date H, Moriwaki K, Ito YM, Kobashi K, Dekura Y, Shimizu S, Shirato H.

J Radiat Res. 2018 Mar 1;59(suppl_1):i72-i76. doi: 10.1093/jrr/rry008.

9.

Regional evaluation of childhood acute lymphoblastic leukemia genetic susceptibility loci among Japanese.

Urayama KY, Takagi M, Kawaguchi T, Matsuo K, Tanaka Y, Ayukawa Y, Arakawa Y, Hasegawa D, Yuza Y, Kaneko T, Noguchi Y, Taneyama Y, Ota S, Inukai T, Yanagimachi M, Keino D, Koike K, Toyama D, Nakazawa Y, Kurosawa H, Nakamura K, Moriwaki K, Goto H, Sekinaka Y, Morita D, Kato M, Takita J, Tanaka T, Inazawa J, Koh K, Ishida Y, Ohara A, Mizutani S, Matsuda F, Manabe A.

Sci Rep. 2018 Jan 15;8(1):789. doi: 10.1038/s41598-017-19127-7.

10.

Postdischarge Light-Intensity Physical Activity Predicts Rehospitalization of Older Japanese Patients With Heart Failure.

Miyahara S, Fujimoto N, Dohi K, Sugiura E, Moriwaki K, Omori T, Takeuchi T, Kumagai N, Nakamori S, Yamada N, Ito M.

J Cardiopulm Rehabil Prev. 2018 May;38(3):182-186. doi: 10.1097/HCR.0000000000000296.

PMID:
29251652
11.

Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.

Inoue Y, Moriwaki K, Ueda Y, Takeuchi T, Higuchi K, Asahi M.

Biochem Biophys Res Commun. 2018 Jan 8;495(2):1681-1687. doi: 10.1016/j.bbrc.2017.11.179. Epub 2017 Dec 2.

PMID:
29196265
12.

W9 peptide enhanced osteogenic differentiation of human adipose-derived stem cells.

Otsuki Y, Ii M, Moriwaki K, Okada M, Ueda K, Asahi M.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):904-910. doi: 10.1016/j.bbrc.2017.11.056. Epub 2017 Nov 14.

13.

Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.

Ishimura E, Nakagawa T, Moriwaki K, Hirano S, Matsumori Y, Asahi M.

Cancer Sci. 2017 Dec;108(12):2373-2382. doi: 10.1111/cas.13412. Epub 2017 Oct 21.

14.

Enhancing Study Motivation and Efficacy among First-year Students Using Minute Papers in the Interdisciplinary Subject of Yakugaku Nyumon.

Yamaki K, Ikeda K, Ueda K, Habu Y, Nakayama Y, Takeda N, Moriwaki K, Wada A, Koyama J, Kodama N, Kitagawa S.

Yakugaku Zasshi. 2017;137(10):1285-1299. doi: 10.1248/yakushi.17-00035. Japanese.

15.

Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea.

Minami D, Ando C, Sato K, Moriwaki K, Sugahara F, Nakasuka T, Iwamoto Y, Fujiwara K, Shibayama T, Yonei T, Sato T.

Intern Med. 2017 Nov 1;56(21):2907-2911. doi: 10.2169/internalmedicine.8269-16. Epub 2017 Sep 25.

16.

[Cost-effectiveness of implementing Osteoporosis Liaison Service program.]

Moriwaki K.

Clin Calcium. 2017;27(9):1295-1301. doi: CliCa170912951301. Japanese.

PMID:
28912393
17.

Effect of Anemia on Cardiovascular Hemodynamics, Therapeutic Strategy and Clinical Outcomes in Patients With Heart Failure and Hemodynamic Congestion.

Tanimura M, Dohi K, Fujimoto N, Moriwaki K, Omori T, Sato Y, Sugiura E, Kumagai N, Nakamori S, Kurita T, Fujii E, Yamada N, Ito M.

Circ J. 2017 Oct 25;81(11):1670-1677. doi: 10.1253/circj.CJ-17-0171. Epub 2017 Jun 17.

18.

Augmented TME O-GlcNAcylation Promotes Tumor Proliferation through the Inhibition of p38 MAPK.

Moriwaki K, Asahi M.

Mol Cancer Res. 2017 Sep;15(9):1287-1298. doi: 10.1158/1541-7786.MCR-16-0499. Epub 2017 May 23.

19.

A Survival Case of Fulminant Right-Side Dominant Eosinophilic Myocarditis.

Moriwaki K, Dohi K, Omori T, Tanimura M, Sugiura E, Nakamori S, Sawai T, Imanaka-Yoshida K, Yamada N, Ito M.

Int Heart J. 2017 May 31;58(3):459-462. doi: 10.1536/ihj.16-338. Epub 2017 May 12.

20.

BIG1 is required for the survival of deep layer neurons, neuronal polarity, and the formation of axonal tracts between the thalamus and neocortex in developing brain.

Teoh JJ, Iwano T, Kunii M, Atik N, Avriyanti E, Yoshimura SI, Moriwaki K, Harada A.

PLoS One. 2017 Apr 17;12(4):e0175888. doi: 10.1371/journal.pone.0175888. eCollection 2017.

21.

Erratum to: Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.

Moriwaki K, Mouri M, Hagino H.

Osteoporos Int. 2017 Jun;28(6):1951-1952. doi: 10.1007/s00198-017-4006-3. No abstract available.

PMID:
28324132
22.

Fulminant Myocarditis With Prolonged Active Lymphocytic Infiltration After Hemodynamic Recovery.

Tanimura M, Dohi K, Imanaka-Yoshida K, Omori T, Moriwaki K, Nakamori S, Yamada N, Ito M.

Int Heart J. 2017 Apr 6;58(2):294-297. doi: 10.1536/ihj.16-225. Epub 2017 Mar 21.

23.

Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan.

Shiroiwa T, Fukuda T, Ikeda S, Takura T, Moriwaki K.

Value Health. 2017 Mar;20(3):372-378. doi: 10.1016/j.jval.2016.08.726. Epub 2016 Oct 21.

24.

Distinct Kinase-Independent Role of RIPK3 in CD11c+ Mononuclear Phagocytes in Cytokine-Induced Tissue Repair.

Moriwaki K, Balaji S, Bertin J, Gough PJ, Chan FK.

Cell Rep. 2017 Mar 7;18(10):2441-2451. doi: 10.1016/j.celrep.2017.02.015.

25.

Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.

Moriwaki K, Mouri M, Hagino H.

Osteoporos Int. 2017 Jun;28(6):1939-1950. doi: 10.1007/s00198-017-3973-8. Epub 2017 Mar 6. Erratum in: Osteoporos Int. 2017 Jun;28(6):1951-1952.

26.

Cost effectiveness of the occupation-based approach for subacute stroke patients: result of a randomized controlled trial.

Nagayama H, Tomori K, Ohno K, Takahashi K, Nagatani R, Izumi R, Moriwaki K, Yamauchi K.

Top Stroke Rehabil. 2017 Jul;24(5):337-344. doi: 10.1080/10749357.2017.1289686. Epub 2017 Feb 15.

PMID:
28198661
27.

The Inflammatory Signal Adaptor RIPK3: Functions Beyond Necroptosis.

Moriwaki K, Chan FK.

Int Rev Cell Mol Biol. 2017;328:253-275. doi: 10.1016/bs.ircmb.2016.08.007. Epub 2016 Sep 22. Review.

28.

Caveolae-specific activation loop between CaMKII and L-type Ca2+ channel aggravates cardiac hypertrophy in α1-adrenergic stimulation.

Tonegawa K, Otsuka W, Kumagai S, Matsunami S, Hayamizu N, Tanaka S, Moriwaki K, Obana M, Maeda M, Asahi M, Kiyonari H, Fujio Y, Nakayama H.

Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H501-H514. doi: 10.1152/ajpheart.00601.2016. Epub 2016 Dec 30.

29.

A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.

Yoshimura M, Moriwaki K, Noto S, Takiguchi T.

Osteoporos Int. 2017 Feb;28(2):643-652. doi: 10.1007/s00198-016-3782-5. Epub 2016 Oct 14.

PMID:
27743068
30.

Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.

Moriwaki K, Noto S.

Osteoporos Int. 2017 Feb;28(2):621-632. doi: 10.1007/s00198-016-3777-2. Epub 2016 Oct 4.

PMID:
27699441
31.

ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yaguchi A, Terada K, Saito Y, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fujimura J, Hino M, Kinoshita A, Kakuda H, Kurosawa H, Kato K, Kajiwara R, Moriwaki K, Morimoto T, Nakamura K, Noguchi Y, Osumi T, Sakashita K, Takita J, Yuza Y, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Fukushima T, Koh K, Manabe A, Ohara A, Kiyokawa N; Tokyo Children’s Cancer Study Group (TCCSG).

Haematologica. 2017 Jan;102(1):118-129. doi: 10.3324/haematol.2016.151035. Epub 2016 Sep 15.

32.

Tracking isolated myocarditis in a young adult with acute rheumatic fever on cardiac magnetic resonance imaging.

Moriwaki K, Okamoto R, Sakuma H, Suzuki Y, Tanabe M, Yamada N, Ito M.

Int J Cardiol. 2016 Nov 1;222:921-923. doi: 10.1016/j.ijcard.2016.08.087. Epub 2016 Aug 6. No abstract available.

PMID:
27526359
33.

[A Multicenter Questionnaire Survey of Postoperative Delirium -National Hospital Organization, Surgery and Anesthesia Network Group-].

Siuciuno T, Shimakawa N, Shibuya H, Suzuki H, Ozawa A, Moriwaki K, Hirao M.

Masui. 2016 Aug;65(7):756-762. Japanese.

PMID:
30358310
34.

Border Security: The Role of RIPK3 in Epithelium Homeostasis.

Moriwaki K, Balaji S, Chan FK.

Front Cell Dev Biol. 2016 Jun 28;4:70. doi: 10.3389/fcell.2016.00070. eCollection 2016.

35.

Interdisciplinary Subject "Yakugaku Nyumon" for First-year Students Constructed with Lectures and Problem-based Learning.

Yamaki K, Ueda M, Ueda K, Emoto N, Mizutani N, Ikeda K, Yagi K, Tanaka M, Habu Y, Nakayama Y, Takeda N, Moriwaki K, Kitagawa S.

Yakugaku Zasshi. 2016;136(7):1051-64. doi: 10.1248/yakushi.15-00255. Japanese.

36.

Flt1/VEGFR1 heterozygosity causes transient embryonic edema.

Otowa Y, Moriwaki K, Sano K, Shirakabe M, Yonemura S, Shibuya M, Rossant J, Suda T, Kakeji Y, Hirashima M.

Sci Rep. 2016 Jun 2;6:27186. doi: 10.1038/srep27186.

37.

Cost-Effectiveness Analysis of Safety-Engineered Devices.

Fukuda H, Moriwaki K.

Infect Control Hosp Epidemiol. 2016 Sep;37(9):1012-21. doi: 10.1017/ice.2016.110. Epub 2016 May 26.

PMID:
27226284
38.

Necroptosis-independent signaling by the RIP kinases in inflammation.

Moriwaki K, Chan FK.

Cell Mol Life Sci. 2016 Jun;73(11-12):2325-34. doi: 10.1007/s00018-016-2203-4. Epub 2016 Apr 5. Review.

39.

Diagnostic and prognostic factors for acute encephalopathy.

Motojima Y, Nagura M, Asano Y, Arakawa H, Takada E, Sakurai Y, Moriwaki K, Tamura M.

Pediatr Int. 2016 Nov;58(11):1188-1192. doi: 10.1111/ped.12995. Epub 2016 Jul 24.

PMID:
27037936
40.

A glycoproteomic approach to identify novel glycomarkers for cancer stem cells.

Sawanobori A, Moriwaki K, Takamatsu S, Kamada Y, Miyoshi E.

Proteomics. 2016 Dec;16(24):3073-3080. doi: 10.1002/pmic.201500472. Epub 2016 May 9. Review.

PMID:
26949200
41.

Controlling the Polarity of Fullerene Derivatives to Optimize Nanomorphology in Blend Films.

Matsumoto F, Iwai T, Moriwaki K, Takao Y, Ito T, Mizuno T, Ohno T.

ACS Appl Mater Interfaces. 2016 Feb;8(7):4803-10. doi: 10.1021/acsami.5b11180. Epub 2016 Feb 10.

PMID:
26862987
42.

Regulation of RIPK3- and RHIM-dependent Necroptosis by the Proteasome.

Moriwaki K, Chan FK.

J Biol Chem. 2016 Mar 11;291(11):5948-59. doi: 10.1074/jbc.M115.700997. Epub 2016 Jan 19.

43.

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report.

Kurita S, Moriwaki K, Shiroyama K, Sanuki M, Toyota Y, Takebayashi M.

JA Clin Rep. 2016;2(1):28. doi: 10.1186/s40981-016-0055-4. Epub 2016 Oct 10.

44.

The Mitochondrial Phosphatase PGAM5 Is Dispensable for Necroptosis but Promotes Inflammasome Activation in Macrophages.

Moriwaki K, Farias Luz N, Balaji S, De Rosa MJ, O'Donnell CL, Gough PJ, Bertin J, Welsh RM, Chan FK.

J Immunol. 2016 Jan 1;196(1):407-15. doi: 10.4049/jimmunol.1501662. Epub 2015 Nov 18.

45.

Validation of Fracture Risk Model In Japanese Women Compared With Frax.

Moriwaki K, Noto S.

Value Health. 2015 Nov;18(7):A698. doi: 10.1016/j.jval.2015.09.2606. Epub 2015 Oct 20. No abstract available.

46.

Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients.

Noto S, Izumi R, Shiroiwa T, Igarashi A, Ikeda S, Fukuda T, Saito S, Shimozuma K, Kobayashi M, Moriwaki K, Ishida H.

Value Health. 2015 Nov;18(7):A397. doi: 10.1016/j.jval.2015.09.903. Epub 2015 Oct 20. No abstract available.

47.

[Cost-effectiveness considerations in the treatment of osteoporosis].

Moriwaki K.

Nihon Rinsho. 2015 Oct;73(10):1754-9. Japanese.

PMID:
26529942
48.

Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.

Hirase S, Hasegawa D, Takahashi H, Moriwaki K, Saito A, Kozaki A, Ishida T, Yanai T, Kawasaki K, Yamamoto N, Kubokawa I, Mori T, Hayakawa A, Nishimura N, Nishio H, Iijima K, Kosaka Y.

Int J Hematol. 2015 Nov;102(5):594-601. doi: 10.1007/s12185-015-1875-0. Epub 2015 Oct 6.

PMID:
26440971
49.

Diuretic effects of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and heart failure.

Takeuchi T, Dohi K, Omori T, Moriwaki K, Sato Y, Nakamori S, Fujimoto N, Fujii E, Yamada N, Ito M.

Int J Cardiol. 2015 Dec 15;201:1-3. doi: 10.1016/j.ijcard.2015.07.072. Epub 2015 Jul 31. No abstract available. Erratum in: Int J Cardiol. 2016 Mar 1;206:173.

PMID:
26278671
50.

Erratum to: Cytogenetics and clinical features of pediatric myelodysplastic syndrome in Japan.

Moriwaki K, Manabe A, Taketani T, Kikuchi A, Nakahata T, Hayashi Y.

Int J Hematol. 2015 Aug;102(2):249. doi: 10.1007/s12185-015-1834-9.

Supplemental Content

Loading ...
Support Center